The Hanover Insurance Group, Inc. filings document the regulatory record of a property and casualty insurance holding company with common stock listed on the New York Stock Exchange. Its 8-K reports include results of operations and financial condition, earnings releases and unaudited financial supplements covering underwriting metrics, catastrophe losses, premiums, investment income, book value and related insurance performance measures.
The company’s proxy materials cover annual meeting procedures, shareholder voting matters, board governance and executive compensation disclosures. Other filings record capital-structure activity, including senior unsecured notes, note redemptions, registration-statement references and Form 25 records for the removal of a senior debenture class from exchange listing and registration.
Hanover Insurance Group President and CEO John C. Roche exercised stock options and then sold a portion of the resulting shares under a pre-established Rule 10b5-1 Trading Plan. On May 19, 2026, he exercised options for 33,124 shares of common stock at strike prices of $104.11 and $85.87 per share. The company withheld 24,766 shares to cover the exercise price and related taxes, resulting in a net issuance of 8,358 shares. On May 20, 2026, those 8,358 shares were sold in open-market transactions at weighted average prices around $193–$195 per share pursuant to the Rule 10b5-1 plan. After these transactions, Roche directly owns 141,010.748 shares of Hanover Insurance Group common stock, and this figure does not include 14,454 shares held by his spouse.
HANOVER INSURANCE GROUP Executive Vice President Dennis Francis Kerrigan executed an exercise-and-sell stock transaction. He exercised options to acquire 6,262 shares of Common Stock at $115.35 per share and, on the same date, sold 6,262 shares in an open-market sale at $192.99 per share.
Following these transactions, Kerrigan directly owns 11,987.721 shares of Hanover Insurance Group common stock. The exercised option covered 6,262 shares and is now fully used, with no remaining balance from that grant.
Fidelity Brokerage Services LLC filed a Form 144 notice relating to proposed sale of Common stock. The filing lists 1,000 shares and a figure of 34,986,787 (numeric field shown) with an entry date of 05/21/2026, and references prior compensation-related entries dated 06/16/2022 and 05/22/2023.
Hanover Insurance Group, Inc. (THG) officer and director John C. Roche gave notice of a proposed sale of 8,358 common shares, with an aggregate market value of $1,625,045.94 and an approximate sale date of May 20, 2026. The notice reports a Rule 10b5-1 plan adoption date of November 19, 2025. It also records that Roche acquired 8,358 shares through a cash-paid stock option exercise from the issuer on May 19, 2026, and sold 5,251 common shares on May 18, 2026, for gross proceeds of $1,040,036.44.
Hanover Insurance Group President and CEO John C. Roche exercised options for 18,194 shares of common stock at an exercise price of $85.87 per share. The company withheld 12,943 shares to cover the exercise price and taxes, and the remaining 5,251 shares were sold in open-market transactions at prices near $197 under a pre-established Rule 10b5-1 trading plan. Following these transactions, Roche directly holds 141,010.748 shares of Hanover common stock, not including 14,454 shares held by his spouse.
Hanover Insurance Group Executive Vice President Denise Lowsley exercised options to acquire 4,175 shares of common stock at $115.35 per share and, on the same day, sold 4,175 shares in an open-market transaction at $191.73 per share. Following these transactions, she holds 3,882.513 common shares directly.
THG filed a Form 144 notice reporting a sale of securities by Denise Lowsley. The notice lists 4,175 shares associated with an option granted 02/26/2021 and a transaction date of 05/14/2026. The excerpt also shows 1,062 shares sold in the past three months for $200,107.35, and a figure of $800,472.75 alongside the 4,175‑share line. Shares outstanding are listed as 34,986,787 as of 05/14/2026.
Donnell William E. reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director William E. Donnell received an equity award of 843 shares of common stock. The shares were granted at no cash cost as restricted stock units under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of one year from the grant date or the next annual shareholder meeting. After this award, Donnell holds 843 shares directly, and a footnote notes an additional 977 shares held indirectly in a Rabbi Trust under deferral agreements.